| 2026-09-15 | Transcript | Earnings call transcript |
| 2026-09-03 | 8-K | Form 8-K, Item 7.01 |
| 2026-08-31 | Press release | AbbVie to Present at the Wells Fargo 21st Annual Healthcare Conference |
| 2026-08-18 | 8-K | Form 8-K, Item 8.01 |
| 2026-08-05 | 8-K | Form 8-K, Item 8.01 |
| 2026-08-03 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-31 | Deck | AbbVie Pipeline Update |
| 2026-07-31 | Press release | AbbVie Reports Second-Quarter 2026 Financial Results |
| 2026-07-31 | Press release | AbbVie Reports Second-Quarter 2026 Financial Results |
| 2026-07-31 | 8-K | Form 8-K, Item 2.02 results |
| 2026-07-31 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-06 | 8-K | Form 8-K, Item 2.02 results |
| 2026-06-26 | Press release | AbbVie to Host Second-Quarter 2026 Earnings Conference Call |
| 2026-06-22 | Deck | AbbVie Apogee Acquisition – Slides |
| 2026-06-22 | Press release | AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio |
| 2026-06-22 | 8-K | Form 8-K, Item 7.01 |
| 2026-06-02 | Press release | AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference |
| 2026-05-12 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-08 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-05-06 | Press release | AbbVie to Present at the Bank of America Securities Healthcare Conference |
| 2026-04-29 | Press release | AbbVie Reports First-Quarter 2026 Financial Results |
| 2026-04-29 | Press release | AbbVie Reports First-Quarter 2026 Financial Results |
| 2026-04-29 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-29 | Transcript | Q1 FY26 earnings call transcript |
| 2026-04-28 | Deck | AbbVie Pipeline Update |
| 2026-04-03 | 8-K | Form 8-K, Item 2.02 results |
| 2026-03-31 | Press release | AbbVie to Host First-Quarter 2026 Earnings Conference Call |
| 2026-03-23 | Proxy | Definitive proxy statement |
| 2026-03-04 | 8-K | Form 8-K, Item 8.01 |
| 2026-03-03 | Press release | AbbVie to Present at the Leerink Partners Global Healthcare Conference |
| 2026-02-26 | 8-K | Form 8-K, Item 8.01 |
| 2026-02-24 | Press release | AbbVie to Present at the TD Cowen 46th Annual Health Care Conference |
| 2026-02-20 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-04 | Press release | AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial Results |
| 2026-02-04 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-04 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-02 | Deck | AbbVie Pipeline Update |
| 2026-01-07 | Press release | AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call |
| 2026-01-07 | 8-K | Form 8-K, Item 2.02 results |
| 2026-01-05 | Press release | AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference |